Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric Cancer
Conditions
Esophageal Neoplasms - Stomach Neoplasms
Conditions: official terms
Esophageal Neoplasms - Neoplasms - Stomach Neoplasms
Conditions: Keywords
non-interventional, advanced gastric cancer, Trastuzumab, HER2
Study Type
Observational [Patient Registry]
Study Phase
N/A
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Intervention
Name: non-interventional
Type: Other
Overall Status
Recruiting
Summary
The aim of this study is to identify biomarkers predicting response or resistance factors of a targeted therapy with trastuzumab in advanced gastric cancer.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- histologically proven adenocarcinoma of the stomach or gastroesophageal junction

- stage IV

- patient receives chemotherapy

- signed informed consent

- Age > 18 years

Exclusion Criteria:

- Patient can not understand meaning and purpose of the study

- patient already received a chemotherapy treatment for advanced disease.
Location
University Cancer Center Leipzig
Leipzig, Germany
Status: Recruiting
Start Date
March 2014
Sponsors
University of Leipzig
Source
University of Leipzig
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page